Short Interest in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Decreases By 27.6%

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) was the recipient of a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 13,100 shares, a drop of 27.6% from the August 15th total of 18,100 shares. Based on an average trading volume of 7,300 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.0% of the shares of the company are sold short.

Institutional Trading of Creative Medical Technology

A hedge fund recently bought a new stake in Creative Medical Technology stock. Aaron Wealth Advisors LLC purchased a new stake in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,400 shares of the company’s stock, valued at approximately $85,000. Aaron Wealth Advisors LLC owned approximately 1.21% of Creative Medical Technology as of its most recent filing with the Securities and Exchange Commission (SEC). 1.42% of the stock is currently owned by institutional investors and hedge funds.

Creative Medical Technology Price Performance

Shares of NASDAQ:CELZ opened at $3.39 on Tuesday. The stock has a market cap of $4.58 million, a price-to-earnings ratio of -0.91 and a beta of 2.11. Creative Medical Technology has a 12 month low of $2.90 and a 12 month high of $10.28. The stock’s 50 day moving average price is $3.42 and its 200 day moving average price is $4.21.

Creative Medical Technology (NASDAQ:CELZ) last announced its earnings results on Friday, August 9th. The company reported ($1.11) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.27). The company had revenue of $0.01 million during the quarter. On average, sell-side analysts expect that Creative Medical Technology will post -3.29 EPS for the current year.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.